International Delegations at BioTrinity

BioTrinity welcomes international delegations from across the world.  Bringing a delegation will help raise the profile of the state, bioregion or cluster association, as well as highlight the companies that are part of that delegation. Your group will get access to senior pharmaceutical, biotech and investors executives that attend BioTrinity.  There are a number of delegation benefits listed below, and also a  number of ready-made Delegation Packages to simplify organising a delegation within a fixed budget.

2014 International Delegation Benefits

  • Discounted registration fees are available for all members of a delegation, including the hosts
  • BioTrinity welcomes delegations of any size
  • Access to value-for-money tailored packages or fixed packages to simplify organisation

Package Options Can Include:

  • Choice of exhibition space
  • Full partnering delegate registrations (including all social networking events) for delegation organising staff
  • Exhibitor-only passes
  • Pre conference promotion of delegation via prominently displayed logo on website and listed in promotional material as a Sponsor Company
  • Company logo in Conference Handbook
  • One piece of marketing for delegation inserted into delegate bag insert
  • Logo prominently displayed during the conference as Sponsor Company
  • Private receptions within the conference venue
  • Satellite meetings during the conference
  • Private partnering meeting room

Smaller Delegations

BioTrinity can also cater for smaller delegations - contact David Boal to discuss your requirements (david.boal@obn.org.uk / +44 (0) 845 5049 743).

Contact Us Today

We welcome your questions and enquiries, please contact David Boal for an initial discussion on +44 (0) 845 5049 743. OBN will do its upmost to make sure your member companies get the most from BioTrinity.





BioTrinity 2013 highlights
877 delegates from 28 countries
520 companies
168 speakers
86 company presentations
1679 scheduled one-to-one meetings
97 investors from 11 countries
66 exhibitors
32 global pharma/corporate venture